Instrument number PB 76 of 2007
Amendment special arrangements under subparagraph 100(1)(b)(i) of the National Health Act 1953
I, STEPHEN DELLAR, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, make this instrument under subparagraph 100(1)(b)(i) of the National Health Act 1953.
Dated 14 Sept 2007
STEPHEN DELLAR
Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment Special Arrangements — IVF/GIFT Program
1 Commencement
This instrument commences on 1 October 2007.
2 Amendment of PB 26 of 2007
Schedule 1 amends PB 26 of 2007.
Schedule 1 Amendments
(section 2)
[1] The Schedule, Part 1, item dealing with Choriogonadotropin Alfa
omit from the column headed “Manufacturer”:
Serono Australia Pty Ltd (SG)
and substitute:
Merck Serono Australia Pty Ltd (SG)
[2] The Schedule, Part 1, items dealing with Follitropin Alfa
omit from the column headed “Manufacturer”:
Serono Australia Pty Ltd (SG)
and substitute:
Merck Serono Australia Pty Ltd (SG)
[3] The Schedule, Part 2, item dealing with Progesterone in the form Vaginal gel (prolonged release) 90 mg in single dose pre-filled applicator
omit from the column headed “Manufacturer”:
Serono Australia Pty Ltd (SG)
and substitute:
Merck Serono Australia Pty Ltd (SG)